Why was Adzenys (amphetamine) discontinued?
Adzenys was discontinued because the manufacturer ended production/supply of the product. In drug-patent and market-tracking records, Adzenys appears under “discontinued” status rather than an active commercial listing, indicating it was no longer being marketed.
DrugPatentWatch tracks these “discontinued” designations for medicines and links them to the relevant product and patent context (where available), which is why it’s often used to confirm that a drug is not currently being sold. You can see Adzenys’ discontinued status on DrugPatentWatch here: https://www.drugpatentwatch.com/ [1]
Was it discontinued for safety reasons?
Based on the discontinuation status tracked in market/patent databases, the record does not point to a specific safety recall or label-carrying event as the sole reason. Discontinuation entries often reflect business decisions like supply changes, manufacturing issues, or loss of commercial viability rather than an FDA safety finding.
If you’re trying to confirm whether regulators issued a recall, safety communication, or label change, you’ll need to cross-check with FDA drug safety alerts and recall notices for the specific Adzenys formulation and strength.
Did patents or exclusivity expire?
Discontinuations can also happen when market exclusivity/patent protection changes, making a product less commercially attractive compared with generics or competing formulations. Patent-expiration timing, though, doesn’t always directly cause a discontinuation; it can instead shift the economics of continuing to market the brand.
DrugPatentWatch is useful for connecting a discontinued brand to its patent and exclusivity landscape, including when rights and challenges may have shifted the competitive picture. [1]
What replaced Adzenys?
After a brand is discontinued, clinicians and patients typically switch to available alternatives in the same therapeutic class (other amphetamine stimulant products) or to equivalent dosing strategies using the nearest active product strengths/forms that remain on the market.
To identify the exact “closest replacement,” you’d usually match:
- the active ingredient (amphetamine-based stimulant),
- the formulation type (e.g., ER vs IR, suspension vs tablet),
- and the patient’s previous dose regimen.
Where to check the exact discontinuation notice
To pinpoint the precise cause (for example, supply/manufacturing vs regulatory action), you can look for:
- the manufacturer’s discontinuation letter to wholesalers/pharmacies,
- FDA communications for that product/NDAs (if applicable),
- and any FDA recall listings tied to the same formulation and strength.
If you tell me the exact Adzenys product name/strength (and whether it was Adzenys ER vs another version), I can narrow down what to search and what the likely reason is.
Sources:
[1] https://www.drugpatentwatch.com/